Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-04-17 @ 12:48 PM
Study NCT ID:
NCT05736835
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-17
First Post:
2023-02-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
Sponsor:
CyanVac LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CVXGA-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None